Table 2.

BP targets

SocietyWhen to Start TreatmentTreatment Goals
ACOG (89)≥160/105 for chronic HTN or 160/110 for gestational HTN or preeclampsia120–160/80–105 for chronic HTN
SOGC (90)BP lowered to <160/110 in severe HTN or BP of 140–159/90–109 for nonsevere HTN with comorbid conditions130–155/80–105 for nonsevere HTN without comorbid conditionsa or <140/90 nonsevere HTN with comorbid conditions
NICE (www.nice.org.uk/guidance/cg107)>150/100 for uncomplicated chronic HTN/gestational HTN/preeclampsia or >140/90 for target organ damage secondary to chronic HTN<150/100 but diastolic BP >80 for chronic HTN or <150/80–100 for gestational HTN and preeclampsia
SOMANZ (91)≥160/110 for mild to moderate HTN or ≥170/110 for severe HTNNone recommended
ISSHP (92)160–170/110 for preeclampsiaNone recommended
  • Numbers indicate systolic BP/diastolic BP in millimeters of mercury. ACOG, American College of Obstetrics and Gynecology; HTN, hypertension; SOGC, Society of Obstetricians and Gynecologists of Canada; NICE, National Institute for Health and Care Excellence; SOMANZ, Society of Obstetric Medicine of Australia and New Zealand; ISSHP, International Society for the Study of Hypertension in Pregnancy.

  • a Comorbid conditions: pregestational type 1 or 2 diabetes mellitus or kidney disease.